A
ADAPTIVE BIOTECHNOLOGIES CORP
NASDAQ: ADPT (Adaptive Biotechnologies Corpor)
Kemas kini terakhir: 5 jam lalu12.85
0.44 (3.55%)
| Penutupan Terdahulu | 12.41 |
| Buka | 12.41 |
| Jumlah Dagangan | 1,807,072 |
| Purata Dagangan (3B) | 2,000,921 |
| Modal Pasaran | 1,978,663,168 |
| Harga / Jualan (P/S) | 7.44 |
| Harga / Buku (P/B) | 9.56 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Apr 2026 |
| Margin Keuntungan | -74.84% |
| Margin Operasi (TTM) | -56.45% |
| EPS Cair (TTM) | -0.950 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 25.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 115.90% |
| Nisbah Semasa (MRQ) | 2.92 |
| Aliran Tunai Operasi (OCF TTM) | -85.34 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -21.40 M |
| Pulangan Atas Aset (ROA TTM) | -15.05% |
| Pulangan Atas Ekuiti (ROE TTM) | -61.03% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Adaptive Biotechnologies Corpor | Menaik | Menaik |
AISkor Stockmoo
-1.1
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.10 |
|
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL). |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 2.35% |
| % Dimiliki oleh Institusi | 98.36% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Viking Global Investors Lp | 31 Dec 2025 | 29,993,708 |
| Price T Rowe Associates Inc /Md/ | 31 Dec 2025 | 4,387,361 |
| Westfield Capital Management Co Lp | 31 Dec 2025 | 4,060,481 |
| Lord, Abbett & Co. Llc | 31 Dec 2025 | 3,080,759 |
| Driehaus Capital Management Llc | 31 Dec 2025 | 2,760,387 |
| Jennison Associates Llc | 31 Dec 2025 | 2,674,668 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 22.00 (BTIG, 71.21%) | Beli |
| Median | 21.00 (63.42%) | |
| Rendah | 21.00 (Guggenheim, 63.42%) | Beli |
| 21.00 (JP Morgan, 63.42%) | Beli | |
| Purata | 21.33 (65.99%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 16.89 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 06 Feb 2026 | 22.00 (71.21%) | Beli | 15.77 |
| JP Morgan | 06 Feb 2026 | 21.00 (63.42%) | Beli | 15.77 |
| Guggenheim | 26 Jan 2026 | 21.00 (63.42%) | Beli | 19.12 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| RUBINSTEIN JULIE | - | 13.68 | -152,480 | -2,085,545 |
| Jumlah Keseluruhan Kuantiti Bersih | -152,480 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -2,085,545 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 13.68 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE | Pegawai | 26 Mar 2026 | Jual automatik (-) | 19,060 | 13.96 | 266,078 |
| RUBINSTEIN JULIE | Pegawai | 26 Mar 2026 | Pelaksanaan pilihan | 14,722 | - | - |
| RUBINSTEIN JULIE | Pegawai | 25 Mar 2026 | Jual automatik (-) | 19,060 | 14.15 | 269,699 |
| RUBINSTEIN JULIE | Pegawai | 25 Mar 2026 | Pelaksanaan pilihan | 14,722 | - | - |
| RUBINSTEIN JULIE | Pegawai | 24 Mar 2026 | Jual automatik (-) | 19,060 | 13.90 | 264,934 |
| RUBINSTEIN JULIE | Pegawai | 24 Mar 2026 | Pelaksanaan pilihan | 14,722 | - | - |
| RUBINSTEIN JULIE | Pegawai | 23 Mar 2026 | Jual automatik (-) | 19,060 | 13.66 | 260,360 |
| RUBINSTEIN JULIE | Pegawai | 23 Mar 2026 | Pelaksanaan pilihan | 14,722 | - | - |
| RUBINSTEIN JULIE | Pegawai | 20 Mar 2026 | Jual automatik (-) | 19,060 | 13.58 | 258,835 |
| RUBINSTEIN JULIE | Pegawai | 20 Mar 2026 | Pelaksanaan pilihan | 14,722 | - | - |
| RUBINSTEIN JULIE | Pegawai | 19 Mar 2026 | Jual automatik (-) | 19,060 | 13.50 | 257,310 |
| RUBINSTEIN JULIE | Pegawai | 19 Mar 2026 | Pelaksanaan pilihan | 14,722 | - | - |
| RUBINSTEIN JULIE | Pegawai | 18 Mar 2026 | Jual automatik (-) | 19,060 | 13.28 | 253,117 |
| RUBINSTEIN JULIE | Pegawai | 18 Mar 2026 | Pelaksanaan pilihan | 14,722 | - | - |
| RUBINSTEIN JULIE | Pegawai | 17 Mar 2026 | Jual automatik (-) | 19,060 | 13.39 | 255,213 |
| RUBINSTEIN JULIE | Pegawai | 17 Mar 2026 | Pelaksanaan pilihan | 14,722 | - | - |
| Papar semua | ||||||
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results |
| 27 Jan 2026 | Pengumuman | Adaptive Biotechnologies to Participate in Upcoming Investor Conferences |
| 22 Jan 2026 | Pengumuman | Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 |
| 12 Jan 2026 | Pengumuman | Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |